The association of ultra‐processed food intake with adolescent metabolic dysfunction‐associated steatotic liver disease in the NHANES
Pediatric Obesity · 2025
DOI: 10.1111/ijpo.13174 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Obesity, 2025. Verfasst von Maarten Buytaert und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Pediatrics, Hepatology Research Unit, Ghent University, Ghent, Belgium. Hauptthemen laut MEDLINE: Fast Foods, Fatty Liver, Pediatric Obesity. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Universitair Ziekenhuis Gent, Fonds Wetenschappelijk Onderzoek, Kom op tegen Kanker.
Abstract (Originalsprache)
Introduction
Metabolic dysfunction‐associated steatotic liver disease (MASLD) has become a major public health concern. A thorough analysis of the link between ultra‐processed food (UPF) intake and MASLD in the adolescent population is lacking.
Methods
Adolescent participants of the National Health and Nutrition Examination Survey (NHANES) pre‐pandemic cohort were included. Different controlled attenuation parameter (CAP) cut‐offs were used to assess MASLD. The percentage energy intake of UPF, categorized according to the NOVA classification, to total energy intake was taken as the main outcome marker. Structural equation modelling (SEM) was used to better quantify the causal connection between UPF and liver steatosis.
Results
UPF consumption constituted a median 75% (62–86) of total energy intake. There was no significant correlation between UPF intake and CAP ( ρ = 0.061, p = 0.091). The median proportion UPF intake was not associated with steatosis severity. SEM similarly yielded a weak and non‐significant correlation of 0.078. In participants with MASLD, total energy intake was significantly higher ( p < 0.001) and sugar‐containing beverage (SCB) consumption showed a non‐significant trend towards higher consumption.
Conclusions
No clinically relevant association between UPF intake and MASLD in adolescents could be demonstrated. Our results nonetheless suggest that total energy intake and consumption of SCBs are important contributors to paediatric obesity and MASLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine and Pediatrics, Hepatology Research Unit, Ghent University, Ghent, Belgium.
- Liver Research Center Ghent, Ghent University Hospital, Ghent, Belgium.
- Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
- Center for Nutrition and Dietetics, Ghent University Hospital, Ghent, Belgium.
- Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
- Department of Basic and Applied Medical Sciences, Gut-Liver Immunopharmacology Unit, Ghent University, Ghent, Belgium.
ORCID-Profile: Maarten Buytaert, Sander Lefere
Förderung
- Universitair Ziekenhuis Gent
- Fonds Wetenschappelijk Onderzoek
- Kom op tegen Kanker
Zitieren
APA
Buytaert, M., Declercq, D., Depoorter, F., Cosijn, Z., Devisscher, L., Raevens, S., Verhelst, X., Van Vlierberghe, H., Geerts, A., De Bruyne, R., & Lefere, S. (2025). The association of ultra‐processed food intake with adolescent metabolic dysfunction‐associated steatotic liver disease in the NHANES. Pediatric Obesity. https://doi.org/10.1111/ijpo.13174
Vancouver
Buytaert M, Declercq D, Depoorter F, Cosijn Z, Devisscher L, Raevens S, et al. The association of ultra‐processed food intake with adolescent metabolic dysfunction‐associated steatotic liver disease in the NHANES. Pediatric Obesity. 2025. doi:10.1111/ijpo.13174
BibTeX
@article{Buytaert2025,
author = {Buytaert, Maarten and Declercq, Dimitri and Depoorter, Fleur and Cosijn, Zerlina and Devisscher, Lindsey and Raevens, Sarah and Verhelst, Xavier and Van Vlierberghe, Hans and Geerts, Anja and De Bruyne, Ruth and Lefere, Sander},
title = {The association of ultra‐processed food intake with adolescent metabolic dysfunction‐associated steatotic liver disease in the NHANES},
journal = {Pediatric Obesity},
year = {2025},
doi = {10.1111/ijpo.13174}
}
EUVIMED